Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-041513
Filing Date
2023-08-10
Accepted
2023-08-10 18:27:53
Documents
1
Period of Report
2023-08-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6472
  Complete submission text file 0000950170-23-041513.txt   8008
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Issuer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4500 GREAT AMERICA PKWY STE. 100 #29 SANTA CLARA CA 95054
Business Address
Izumi Raquel E. (Reporting) CIK: 0001832553 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39244 | Film No.: 231161017